Clinical Trial Update: A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MK-0941 in patients with type 2 diabetes mellitus inadequately controlled on metformin was completed, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0941
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2012-10-03